An affinity chromatography system has been developed that retains glycosylated amino acids and peptides. Using this system, synthetic 14 C-glycosylated lysine (reduced with NaB 3 H 4 ) was completely separated from a mixture of reduced 14 C-glycosylated lysine and unmodified 3 H-lysine. Amino acid analysis of the retained peak from hydrolyzed human diabetic hemoglobin previously reduced with NaB 3 H 4 revealed an equimolar mixture of glycosylated valine and glycosylated lysine, in agreement with previously published data obtained using other methodologies. These data demonstrate that in alkaline solution, the NaB 3 H 4 -reducible breakdown products of nonenzymatically glycosylated proteins are adsorbed to m-aminophenyl boronic acid immobilized on Bio-Gel P-6, while nonglycosylated amino acids are not. This affinity chromatography system should facilitate the rapid evaluation of nonenzymatic glycosylation in a large number of diabetic tissues.
brane. 1 " 4 This nonenzymatic glycosylation reaction most probably occurs with other proteins of the body as well, particularly in the insulin-independent tissues of diabetic patients. 5 Although this mechanism may play a role in the pathogenesis of some long-term diabetic complications, extensive investigations of this important hypothesis have been limited by methodologic difficulties, particularly the nonspecific incorporation of radioactivity into nonglycosylated amino acids when tritium is introduced using NaB 3 H 4 . In this report, we describe a newly developed affinity chromatography system that retains glycosylated amino acids and peptides. The method is based on the observation that phenylboronic acid in alkaline solution forms a specific complex with cis-diol groups of sugars. Fructose, with its coplanar cis-diol groups, forms the most stable complex. 6 Since the stable forms of nonenzymatic glycosylation products are known to be 1-deoxyfructosyl derivatives of eamino groups of lysine and a-amino groups of N-terminal amino acids, 7 we have utilized m-aminophenyl boronic acid immobilized on a solid support to separate and quantitate borohydride-reducible nonenzymatically glycosylated amino acids and peptides. The principle of this adsorption is illustrated in Figure 1 . This affinity chromatography system should facilitate the rapid evaluation of nonenzymatic glycosylation in a large number of diabetic tissues. Nonreducible glycosylated amino acids and peptides produced by degradation of glycoproteins having carbohydrate in glycosidic linkage would also be retained by this matrix. Levels of both types of retained compounds in urine from diabetic and normal patients have been determined by measuring ninhydrin-positive material.
MATERIALS AND METHODS
Mete-aminophenyl boronic acid immobilized on Bio-Gel P-6 (Affi-Gel 601) and AG50W-X4 were purchased from BioRad Laboratories (Richmond, California). 3 H-lysine and NaB 3 H 4 were purchased from New England Nuclear (Boston, Massachusetts).
14 C-glycosylated lysine (hydrolyzed N 6 -1 -(1 -deoxyglucitoyl)N 2 -t-butoxycarbonyllysine) was a gift from Dr. Victor Stevens. All other reagents were purchased from Fisher Scientific Company (Springfield, New Jersey). Human diabetic hemoglobin was prepared by a previously described method. 7 Hemoglobin (25 mg) was reacted with tritiated sodium borohydride according to the procedure of Bookchin and Gallop, 8 except that dialysis time was reduced to 24 h. Globin samples were hydrolyzed in 6N HCI in sealed tubes at 105°C for 16 h. After pH adjustment to 9.0, globin hydrolysates were applied to affinity columns as described below. Aliquots (200 fx\) from each fraction were counted in 7.0 ml of hydrofluor (National Diagnostics, Sommerville, New Jersey), in a Packard liquid scintillation counter. Peak tubes from the HCI column elution were pooled and concentrated. Samples were applied to a Beckman Model 119C amino acid analyzer with stream division (90% to the fraction collector, 1.0-ml fractions) and aliquots (500 (x\) were counted in 7.0 ml of hydrofluor. The elution patterns were compared with chromatograms of reduced, hydrolyzed glycosylated valine and reduced, hydrolyzed glycosylated lysine standards.
Twenty-four hour urine samples were collected from nine normal volunteers and thirteen unselected juvenile-onset and maturity-onset diabetic patients. Toluene (10 ml) was added as a preservative during the collection period. Aliquots not analyzed immediately were frozen and stored at -70°C. Aliquots of 24-h urine samples (0.54%, 4.1-34.8 ml) were adjusted to pH 9.0 by adding 1.0 M NaOH. After this pH adjustment the sample was shaken for 15 s on a vortex and then centrifuged (5 min, 12,000 x g) to remove insoluble material. The supernatant fluid was then transferred to the top of a 1.5 x 14-cm boronate column previously equilibrated with 0.025 M sodium phosphate buffer, pH 9.0, made 1.0 mM with NaN 3 . The sample was allowed to flow through the column until the liquid meniscus reached the top of the gel bed. Fresh buffer was then applied to the column and 4.0-ml fractions were collected at a flow rate of 20 ml/h. After 100 fractions were collected, the buffer was removed and the column was eluted with 0.025 M HCI. Fractions (2.0 ml) were collected at a flow rate of 20 ml/h. Aliquots (400 ju,l) from each fraction were assayed for the presence of ninhydrin-positive material, using the method of Moore and Stein. 9 The 2 A 570 was calculated for each peak and compared with the A 570 of leucine standard curves obtained concurrently. Results were expressed both as total /umol of leucine-equivalent excreted per 24 h, and as /u.mol/kg body weight/24 h. Ninhydrin-positive HCI elution peaks from two urine samples were subsequently subjected to tritiated sodium borohydride reduction and acid hydrolysis as described above, and the hydrolysates were applied to columns containing 5 ml of AG50W-X4, -4 0 0 mesh (H + form). After being washed with water until free sugars and NaB 3 H 4 were removed, the resin was eluted with 1.5 N NH 4 OH. Ammonia was removed and the amino acids in the samples were separated on an amino acid analyzer with stream division as described above. When synthetic mixtures of radioactive standards were analyzed, the vortex and centrifugation steps were omitted, 50 buffer fractions (4.0 ml) and 50 HCI fractions (3.0 ml) were collected, and aliquots were counted in 7.0 ml of hydrofluor.
RESULTS AND DISCUSSION

Synthetic
14 C-glycosylated lysine (reduced with NaB 3 H 4 ) was specifically and completely separated from a mixture of reduced 14 C-glycosylated lysine and unmodified 3 H-lysine The chromatographic pattern of hydrolyzed diabetic hemoglobin previously reduced with NaB 3 H 4 showed a peak of nonspecific radioactivity in the void volume (nonglycosylated compounds) and a single sharp peak of radioactivity eluting subsequently with HCI ( Figure 3 ). Amino acid analysis of this peak showed that reduced glycosylated valine ( Figure 4 , peak I) and reduced glycosylated lysine ( Figure  4 , peak II) in approximately equimolar amounts were the only adducts present in the pooled HCI peak. These findings are in agreement with previously published data obtained using other methodologies.
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Urine samples gave essentially identical chromatograms. Washing the column with pH 9.0 sodium phosphate buffer produced a large peak of ninhydrin-positive material in the void volume ( Figure 5 ). After washing the column with 12 column volumes of buffer, changing to 0.025 M HCI resulted in the elution of a single peak of ninhydrin-positive material ( Figure 5 ). Amino acid analysis of NaB 3 H 4 -reduced hydrolysates of these peaks showed that glycosylated lysine was the major borohydride-reducible adduct present (67%-86%).
Comparison of the level of these compounds in urine from diabetic and normal patients shows that the mean level in diabetics is over 1.5 times that found in urine from normal subjects ( Figure 6 ). This difference is highly significant expressed both as /umol leucine-equivalent/24 h (P < 0.001) and as /tmol/24 h/kg body weight (P < 0.005). However, since linear regression analysis shows that the quantity of excreted adducts is significantly correlated with body weight (Figure 7) , the data is presented in this form. The relationship between improving metabolic control and changes in urinary glycosylated amino acids and peptides is currently being investigated.
